Alpha Teknova, Inc.
Alpha Teknova, Inc. (TKNO) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Hollister, United States and has 158 employees. The company is worth $380.11M. Revenue was $40.52M in fiscal 2025, up 7.4% from the year before. It reported a net loss of $17.26M. The share price is 25.3% below its 52-week high of $9.48. 3 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $646.24K. In that quarter, 1 of them reduced the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -68.3% over 5Y.
today you would have $307.96▼ -69.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $3.80 | $8.35 | $3.73 | $5.64 | $20.48 | |
| P/S | 5.0x | 5.0x | 11.8x | 4.2x | 3.8x | 15.6x |
| P/B | 3.0x | 3.0x | 5.4x | 1.7x | 1.6x | 4.0x |
| EPS | -$0.32 | -$0.57 | -$1.16 | -$1.69 | -$0.61 | |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SCTXScribe Therapeutics, Inc. | $20.08 | — | — | 0.00% | — | $380.15M |
| EDITEditas Medicine, Inc. | $2.49 | — | 3.6x | 0.00% | -118.82% | $382.41M |
| TRXBTRex Bio, Inc. | $14.01 | — | — | 0.00% | — | $384.51M |
| CTEVClaritev Corp | $22.12 |
| Profit margin |
| -70.86% |
| -42.59% |
| -70.86% |
| -100.26% |
| -114.60% |
| -26.57% |
| ROE | -32.46% | -25.09% | -32.46% | -40.85% | -47.52% | -6.85% |
Median of the years shown; P/E years above 200x are left out.
| — |
| — |
| 0.00% |
| — |
| $374.88M |
| ZURAZura Bio Ltd | $3.88 | — | 1.9x | 0.00% | -51.01% | $371.82M |
| EMBCEmbecta Corp. | $6.86 | 4.5x | — | 4.66% | — | $388.68M |